CN102177252B - 用于甲状腺癌症的风险评估的遗传变型 - Google Patents

用于甲状腺癌症的风险评估的遗传变型 Download PDF

Info

Publication number
CN102177252B
CN102177252B CN200980139521.2A CN200980139521A CN102177252B CN 102177252 B CN102177252 B CN 102177252B CN 200980139521 A CN200980139521 A CN 200980139521A CN 102177252 B CN102177252 B CN 102177252B
Authority
CN
China
Prior art keywords
risk
markers
thyroid cancer
marker
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980139521.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN102177252A (zh
Inventor
J·甘德姆德森
D·甘伯加特森
P·萨莱姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decode Genetics ehf
Original Assignee
Decode Genetics ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics ehf filed Critical Decode Genetics ehf
Publication of CN102177252A publication Critical patent/CN102177252A/zh
Application granted granted Critical
Publication of CN102177252B publication Critical patent/CN102177252B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/046—Thyroid disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN200980139521.2A 2008-08-12 2009-08-12 用于甲状腺癌症的风险评估的遗传变型 Expired - Fee Related CN102177252B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IS8755 2008-08-12
IS8755 2008-08-12
IS8791 2009-02-05
IS8791 2009-02-05
PCT/IS2009/000010 WO2010018600A1 (en) 2008-08-12 2009-08-12 Genetic variants useful for risk assessment of thyroid cancer

Publications (2)

Publication Number Publication Date
CN102177252A CN102177252A (zh) 2011-09-07
CN102177252B true CN102177252B (zh) 2014-12-24

Family

ID=41217645

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980139521.2A Expired - Fee Related CN102177252B (zh) 2008-08-12 2009-08-12 用于甲状腺癌症的风险评估的遗传变型

Country Status (10)

Country Link
US (1) US20110230366A1 (enExample)
EP (1) EP2334820A1 (enExample)
JP (1) JP2011530306A (enExample)
KR (1) KR20110081807A (enExample)
CN (1) CN102177252B (enExample)
AU (1) AU2009280807A1 (enExample)
CA (1) CA2733910A1 (enExample)
IL (1) IL211177A0 (enExample)
NZ (1) NZ591613A (enExample)
WO (1) WO2010018600A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
NZ593628A (en) * 2008-11-26 2013-07-26 Decode Genetics Ehf Genetic variants useful for risk assessment of thyroid cancer using rs944289
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
EP2686443A4 (en) * 2011-03-17 2014-12-17 Decode Genetics Ehf GENETIC VARIANTS USEFUL IN ESTIMATING THE RISK OF THYROID CANCER
US8718950B2 (en) 2011-07-08 2014-05-06 The Medical College Of Wisconsin, Inc. Methods and apparatus for identification of disease associated mutations
WO2013088457A1 (en) * 2011-12-13 2013-06-20 Decode Genetics Ehf Genetic variants useful for risk assessment of thyroid cancer
US10260103B2 (en) 2012-11-27 2019-04-16 Pontificia Universidad Catolica De Chile Compositions and methods for diagnosing thyroid tumors
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
KR102011383B1 (ko) * 2014-10-31 2019-08-16 에스케이텔레콤 주식회사 갑상선암의 서브타입 분류용 조성물
JP7356788B2 (ja) 2014-11-05 2023-10-05 ベラサイト インコーポレイテッド 機械学習および高次元転写データを使用して経気管支生検における特発性肺線維症を診断するシステムおよび方法
GB201504607D0 (en) * 2015-03-18 2015-05-06 Patia Biopharma S A De C V Methods,tools and systems for the assessment,preventation,management and treatment selection for type 2 diabetes
CN106021992A (zh) * 2015-03-27 2016-10-12 知源生信公司（美国硅谷） 位置相关变体识别计算流水线
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
KR102465122B1 (ko) 2016-02-12 2022-11-09 리제너론 파마슈티칼스 인코포레이티드 비정상적인 핵형을 검출하기 위한 방법 및 시스템
CN106636413B (zh) * 2016-12-28 2019-07-16 常州市第二人民医院 一种用于诊断哮喘的分子标志物
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
CN107194206A (zh) * 2017-06-26 2017-09-22 思畅信息科技（上海）有限公司 一种基于大数据的染色体异常位点的筛选方法
KR102081486B1 (ko) * 2017-08-01 2020-02-25 사회복지법인 삼성생명공익재단 Ahr 분류에 기반한 갑상선암 예후 예측 방법 및 시스템
KR102097540B1 (ko) * 2017-12-26 2020-04-07 주식회사 클리노믹스 질병 및 표현형 위험도 예측 장치 및 방법
CN108315425B (zh) * 2018-04-10 2021-08-06 广东省人民医院(广东省医学科学院) 甲状腺癌转移相关基因检测用的pcr特异性引物、试剂盒及其使用方法
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
KR102169699B1 (ko) * 2019-12-27 2020-10-23 주식회사 클리노믹스 유전자 검사를 위한 맞춤형 유전자칩 및 이의 제작 방법
CN114694836B (zh) * 2020-12-30 2024-06-04 上海交通大学医学院附属瑞金医院 基于甲状腺癌淋巴结转移预测模型的评估系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101608227A (zh) * 2008-06-20 2009-12-23 上海主健生物工程有限公司 甲状腺癌遗传检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5288644A (en) * 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
DE69527585T2 (de) * 1994-06-08 2003-04-03 Affymetrix, Inc. Verfahren und Vorrichtung zum Verpacken von Chips
US6300063B1 (en) * 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
WO1997045559A1 (en) * 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6429027B1 (en) * 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
JP4729030B2 (ja) * 2002-07-31 2011-07-20 株式会社東芝 塩基配列検出装置
JP4994676B2 (ja) * 2006-02-27 2012-08-08 富士通株式会社 遺伝子多型解析支援プログラム、該プログラムを記録した記録媒体、遺伝子多型解析支援装置、および遺伝子多型解析支援方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101608227A (zh) * 2008-06-20 2009-12-23 上海主健生物工程有限公司 甲状腺癌遗传检测试剂盒

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Genome-Wide Profiling of Papillary Thyroid Cancer Identifies MUC1 as an Independent Prognostic Marker;Volkert B. Wreesmann 等;《CANCER RESEARCH》;20040101;第64卷;3780-3789 *
High Prevalence of BRAF Mutations in Thyroid Cancer: Genetic Evidence for Constitutive Activation of the RET/PTC-RAS-BRAF Signaling Pathway in Papillary Thyroid Carcinoma;Edna T. Kimura 等;《CANCER RESEARCH》;20030401;第63卷;1454-1457 *

Also Published As

Publication number Publication date
JP2011530306A (ja) 2011-12-22
IL211177A0 (en) 2011-04-28
CN102177252A (zh) 2011-09-07
CA2733910A1 (en) 2010-02-18
EP2334820A1 (en) 2011-06-22
NZ591613A (en) 2013-01-25
US20110230366A1 (en) 2011-09-22
KR20110081807A (ko) 2011-07-14
WO2010018600A1 (en) 2010-02-18
AU2009280807A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
CN102177252B (zh) 用于甲状腺癌症的风险评估的遗传变型
CN102144036B (zh) 用于乳腺癌风险评估的遗传变型
US8580501B2 (en) Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
US20110287946A1 (en) Genetic Variants Useful for Risk Assessment of Thyroid Cancer
JP5631000B2 (ja) Ｃｈｒ８ｑ２４．２１上の癌感受性変異体
US20110117545A1 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
CA2729931A1 (en) Genetic variants predictive of cancer risk in humans
EP2686443A1 (en) Genetic variants useful for risk assessment of thyroid cancer
US20110020320A1 (en) Genetic Variants Contributing to Risk of Prostate Cancer
WO2009101639A1 (en) Susceptibility variants for lung cancer
AU2008331069B2 (en) Genetic variants on CHR HQ and 6Q as markers for prostate and colorectal cancer predisposition
WO2011095999A1 (en) Genetic variants for predicting risk of breast cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141224

Termination date: 20150812

EXPY Termination of patent right or utility model